Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival

scientific article published on 01 September 2007

Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1227/01.NEU.0000290905.53685.A2
P698PubMed publication ID17881971

P2093author name stringJi Ming Wang
Wen Zhao
Wanghua Gong
Xiang-dong Zhou
Xue-feng Jiang
Zi-qiang Chen
Qing-liang Wang
Xiu-wu Bian
Jian-hong Chen
Yi-fang Ping
Lin-lin Du
Hua-liang Xiao
Jing-quan Shi
Shi-xin Yang
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)570-8; discussion 578-9
P577publication date2007-09-01
P1433published inNeurosurgeryQ7002693
P1476titlePreferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
P478volume61

Reverse relations

cites work (P2860)
Q42545669(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Q55463442A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.
Q48347104A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion
Q57174079A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions
Q35788749Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling
Q34200294CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma
Q33677057CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
Q89805077CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
Q41760694CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma
Q42007327CXCR4 in Cancer and Its Regulation by PPARgamma
Q26781915CXCR4 in breast cancer: oncogenic role and therapeutic targeting
Q36675171CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors
Q33464680Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival
Q37222198Chemokine signaling in cancer: one hump or two?
Q34654670Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma
Q90663490Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
Q37153084Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
Q49671624Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema
Q37175083G-protein coupled chemoattractant receptors and cancer
Q64121793Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation
Q41541275Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis
Q34787997Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT
Q37641240Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
Q37148248KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
Q34032023Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.
Q60938469Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
Q92237972Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
Q64275194Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas
Q36375378Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer
Q34313996Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression
Q35683150Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth
Q50491825Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.
Q38165795Systematic review of protein biomarkers of invasive behavior in glioblastoma
Q36728282Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model
Q35213463Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis
Q64099555Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12
Q39724471The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells
Q39886658The CXCR4/CXCL12 axis in endometrial cancer.
Q53154022The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Q36490004The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
Q48635543The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival
Q37321944The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.
Q38203241The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions
Q38089686The role of the CXCR4 cell surface chemokine receptor in glioma biology
Q24628917Treating brain tumors with PDE4 inhibitors
Q92126841Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer

Search more.